Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26755590 | 0.83 | — | — | |
| SCHEMBL15901921 | 0.79 | TAS1R3 (0.31) | TAS1R3TAS1R1 | |
| SCHEMBL16595519 | 0.76 | TAS1R3 (0.32) | TAS1R3TAS1R1 | |
| SCHEMBL2589220 | 0.76 | TAS1R3 (0.32) | TAS1R3TAS1R1 | |
| SCHEMBL24331980 | 0.75 | — | — | |
| SCHEMBL3279863 | 0.71 | — | — | |
| SCHEMBL13458335 | 0.71 | — | — | |
| SCHEMBL10648742 | 0.69 | LMNA (0.46) | TAS1R3TAS1R1 | |
| SCHEMBL22157396 | 0.68 | TAS1R3 (0.31) | TAS1R3TAS1R1 | |
| SCHEMBL22157397 | 0.68 | TAS1R3 (0.31) | TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023091707-A1 | BICYCLIC INHIBITORS OF JAK AND METHODS OF USE | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2023-05-25 | — | — | WO | disclosed |